Clinical Trial Update: A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating adjunctive aspirin for HIV-negative adults with tuberculous meningitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculous Meningitis

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Tuberculous Meningitis | Phase 2 | Status: COMPLETED